Abstract
Interventions to reduce the likelihood of relapse, or a return to substance abuse after a period of abstinence, are important components of substance abuse treatment. Treatment interventions for adolescence with substance use disorders should incorporate principles of relapse prevention. The relapse prevention model advanced by Marlatt and Gordon and others in the addiction field is a self-control model, based on a cognitive-behavioral approach. This model stands in contrast to a disease model, which many in the medical field have adhered to. This paper presents a summary of the key features of Marlatt and Gordons cognitive-behavioral approach to relapse prevention.
Keywords: Alcohol use disorders, treatment, substance use disorders, Interventions, relapse, abstinence, relapse prevention, addiction, self-control, cognitive-behavioral
Adolescent Psychiatry
Title: Relapse Prevention
Volume: 1 Issue: 2
Author(s): Richard Rosner
Affiliation:
Keywords: Alcohol use disorders, treatment, substance use disorders, Interventions, relapse, abstinence, relapse prevention, addiction, self-control, cognitive-behavioral
Abstract: Interventions to reduce the likelihood of relapse, or a return to substance abuse after a period of abstinence, are important components of substance abuse treatment. Treatment interventions for adolescence with substance use disorders should incorporate principles of relapse prevention. The relapse prevention model advanced by Marlatt and Gordon and others in the addiction field is a self-control model, based on a cognitive-behavioral approach. This model stands in contrast to a disease model, which many in the medical field have adhered to. This paper presents a summary of the key features of Marlatt and Gordons cognitive-behavioral approach to relapse prevention.
Export Options
About this article
Cite this article as:
Rosner Richard, Relapse Prevention, Adolescent Psychiatry 2011; 1 (2) . https://dx.doi.org/10.2174/2210676611101020131
DOI https://dx.doi.org/10.2174/2210676611101020131 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
1-Cyclohexylpiperazine and 3,3-Dimethylpiperidine Derivatives as Sigma-1 (σ1) and Sigma-2 (σ2) Receptor Ligands: A Review
Central Nervous System Agents in Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Climate Change, Climate Variability and Brucellosis
Recent Patents on Anti-Infective Drug Discovery Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy Beneficial Effects of Herbs, Spices and Medicinal Plants on the Metabolic Syndrome, Brain and Cognitive Function
Central Nervous System Agents in Medicinal Chemistry Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification
Recent Patents on Anti-Cancer Drug Discovery A Population-Based Clinicopathological Study in the Oldest-Old: The 90+ Study
Current Alzheimer Research Calcineurin Inhibition and Protein Kinase A Activation Limits Cognitive Dysfunction and Histopathological Damage in a Model of Dementia of the Alzheimer’s Type
Current Neurovascular Research Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Current Topics in Medicinal Chemistry Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Current Drug Targets Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets Biomarkers and Cellular Signal Detection for Alzheimer’s Disease, Stroke, and Immune System Mediated Disorders
Current Neurovascular Research Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors
Current HIV Research Coping With Oxidative Stress. The Yeast Model
Current Drug Targets Cyanopeptides: A New and Nearly Inexhaustible Natural Resource for the Design and Structure-Activity Relationship Studies of New Inhibitors of Trypsin-like Serine Proteases
Current Enzyme Inhibition Recent Patents on Camellia sinensis: Source of Health Promoting Compounds
Recent Patents on Food, Nutrition & Agriculture Xenobiotic and Non-Xenobiotic Interventions in the Microbiome Therapeutics
Current Drug Metabolism Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
Current Neuropharmacology Inhibiting Caspase-6 Activation and Catalytic Activity for Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Disconnection of Language and Memory in Semantic Dementia: A Comparative and Theoretical Analysis
Current Alzheimer Research